Download Citation
Article Source:
Varicella zoster immune globulin (VARIZIG) administration up to 10 days after varicella exposure in pregnant women, immunocompromised participants, and infants: Varicella outcomes and safety results from a large, open-label, expanded-access program
Levin MJ,
Duchon JM,
Swamy GK,
Gershon AA
(2019)
Varicella zoster immune globulin (VARIZIG) administration up to 10 days after varicella exposure in pregnant women, immunocompromised participants, and infants: Varicella outcomes and safety results from a large, open-label, expanded-access program.
PLOS ONE 14(7): e0217749.
https://doi.org/10.1371/journal.pone.0217749